...
首页> 外文期刊>Journal of clinical psychopharmacology >Comparison of Intramuscular Olanzapine, Orally Disintegrating Olanzapine Tablets, Oral Risperidone Solution, and Intramuscular Haloperidol in the Management of Acute Agitation in an Acute Care Psychiatric Ward in Taiwan
【24h】

Comparison of Intramuscular Olanzapine, Orally Disintegrating Olanzapine Tablets, Oral Risperidone Solution, and Intramuscular Haloperidol in the Management of Acute Agitation in an Acute Care Psychiatric Ward in Taiwan

机译:粒蛋白醇,口服崩解奥氮翼片,口服氯化酮溶液和肌内氟哌啶醇在台湾急性护理精神病病房中急性搅拌管理中的比较

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Introduction: The purpose of this study was to compare efficacy and safety among intramuscular olanzapine, intramuscular haloperidol, orally disintegrating olanzapine tablets, and oral risperidone solution for agitated patients with psychosis during the first 24 hours of treatment in an acute care psychiatric ward.Methods: Forty-two inpatients from an acute care psychiatric ward of a medical center in central Taiwan were enrolled. They were randomly assigned to 1 of the 4 treatment groups (10-mg intramuscular olanzapine, 10-mg olanzapine oral disintegrating tablet, 3-mg oral risperidone solution, or 7.5-mg intramuscular haloperidol). Agitation was measured by using the excited component of the Positive and Negative Syndrome Scale (PANSS-EC), the Agitation-Calmness Evaluation Scale, and the Clinical Global Impression-Severity Scale during the first 24 hours.Results: There were significant differences in the PANSS-EC total scores for the 4 intervention groups at 15, 30, 45, 60, 75, and 90 minutes after the initiation of treatment. More significant differences were found early in the treatment. In the post hoc analysis, the patients who received intramuscular olanzapine or orally disintegrating olanzapine tablets showed significantly greater improvement in PANSS-EC scores than did patients who received intramuscular haloperidol at points 15, 30, 45, 60, 75, and 90 minutes after injection.Conclusions: These findings suggest that intramuscular olanzapine, orally disintegrating olanzapine tablets, and oral risperidone solution are as effective treatments as intramuscular haloperidol for patients with acute agitation. Intramuscular olanzapine and disintegrating olanzapine tablets are more effective than intramuscular haloperidol in the early phase of the intervention. There is no significant difference in effectiveness among intramuscular olanzapine, orally disintegrating olanzapine tablets, and oral risperidone solution.
机译:介绍:本研究的目的是在急性护理精神科医疗病房治疗的前24小时内比较肌肉内奥氮平,肌内氟哌啶醇,口服溶解奥桑滨片和口服氯化酮溶液的疗效和安全性。来自台湾中部医疗中心的急性护理精神病病房的四十二个住院患者入学。将它们随机分配给4种治疗组中的1个(10mg肌内奥氮平,10mg奥氮藻口口口崩解片剂,3mg口服锂酮溶液,或7.5mg肌内卤代醇)。通过使用阳性和阴性综合征规模(平移-EC),激动平静评估规模和临床全球印象 - 严重程度的激发成分来测量搅拌。结果:有显着差异平底锅 - 4个干预组的总分数在15,30,45,60,75和治疗后90分钟内和90分钟。治疗早期发现了更大的差异。在后HOC分析中,接受肌内奥氮平或口服崩解奥氮平片剂的患者表现出显着提高平底锅 - EC分数,而不是在注射点15,30,40,60,75和90分钟内接受肌肉内氟哌啶醇的患者。结论:这些研究结果表明,肌内奥氮平,口服崩解奥氮平片剂和口服氯化酮溶液是作为急性搅拌患者的肌肉内氟哌啶醇的有效处理。在干预早期阶段,肌内奥氮平和崩解奥氮翼片剂比肌内氟哌啶醇更有效。肌内奥氮平,口服崩解奥氮平片剂和口服氯化酮溶液中没有显着差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号